Skip to main content
Premium Trial:

Request an Annual Quote

Katherine O Hara, Peter Johnson, Brett Farabaugh, Heiri Gugger, Keith Davis, Doug Morton, Robert Goodman, Susan Harlander, Michael Summers

Premium

Katherine O’Hara will become senior vice president and general counsel of PerkinElmer on May 2, the company said last week.

Most recently, O’Hara was vice president and associate general counsel for Avon Products. O’Hara holds a doctorate of law from Columbia University and an undergraduate degree in economics from Duke University.


Following its recent transformation from an agricultural genomics to a biomarker company, Icoria of Research Triangle Park, NC, last week announced a number of changes in its management and board:

Peter Johnson, executive vice president and chief medical officer, is leaving the company “for personal reasons and to pursue other interests,” according to Icoria. Brett Farabaugh has been promoted to vice president finance, from director of finance and chief accounting officer.

The company also created an “Office of the President” to facilitate the transition, which has the following members: CEO and president Heiri Gugger, who will lead the office; Keith Davis, vice president of agricultural biotechnology; and Doug Morton, a company director and CEO of Southwest Michigan Innovation Center.

Robert Goodman, Susan Harlander, and Michael Summers will step down from the board of directors at the company’s May 11 annual meeting.

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.